The paper also supports our approach by validating that higher chaperone and antioxidant activity correlate with better survival of the host cell
Two names stand out: semaglutide (Ozempic or Wegovy) and tirzepatide (Mounjaro or Zepbound)
Key Takeaways BPC-157 is a Promising Peptide for Lyme Disease: Renowned for its regenerative and anti-inflammatory properties, BPC-157 offers potential benefits for those battling Lyme disease and co-infections by promoting tissue repair, reducing inflammation, and supporting immune function
Because the half-life is measured in minutes to hours
Pricing & access: ~$149/month (starting dose, self-pay) Up to ~$349/month depending on dosage With insurance, costs may drop to ~$25$50/month Safety note: Like other GLP-1 drugs, it carries warnings related to thyroid tumors and requires proper medical supervision
Most patients find that their taste and smell return to normal after 6-12 weeks as the body adjusts to the medication